Sensei Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
08/05
<a href="https://laohu8.com/S/SNSE">Sensei Biotherapeutics</a> Inc reports results for the quarter ended June 30 - Earnings Summary
  • Sensei Biotherapeutics Inc SNSE.OQ reported a quarterly adjusted loss of $3.91​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-5.60. The mean expectation of two analysts for the quarter was for a loss of $5.60 per share. Wall Street expected results to range from $-6.20 to $-5.00 per share.

  • Reported revenue was zero​; analysts expected zero.

  • Sensei Biotherapeutics Inc's reported EPS for the quarter was a loss of $3.91​.

  • The company reported a quarterly loss of $4.94 million.

  • Sensei Biotherapeutics Inc shares had risen by 0.8% this quarter and lost 11.8% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 47.4% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

  • Wall Street's median 12-month price target for Sensei Biotherapeutics Inc is $67.50, about 87.2% above its last closing price of $8.65

This summary was machine generated from LSEG data August 5 at 01:19 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-5.60

-3.91

Beat

Mar. 31 2025

-4.47

-5.40

Missed

Dec. 31 2024

-5.53

-6.20

Missed

Sep. 30 2024

-6.25

-5.80

Beat

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10